"Phoenix" Gram Identification and Drug Susceptibility Test Agent-32
Taiwan·Risk Class 2·BECTON, DICKINSON AND COMPANY (BD)·Registered Jul 12, 2006 – Jul 12, 2026Expired- Analysis ID
- 9c5ec020a594960d5db7ff88b6e53d12
- Customs Code
- DHA00601721700
- Manufacturer
- BECTON, DICKINSON AND COMPANY (BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- Contains selective antimicrobials for rapid identification and susceptibility testing of most human sources of gram-negative aerobic and facultative anaerobic bacteria.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
- Registration Date
- Jul 12, 2006
- Expiry Date
- Jul 12, 2026
Access comprehensive regulatory information for "Phoenix" Gram Identification and Drug Susceptibility Test Agent-32 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9c5ec020a594960d5db7ff88b6e53d12 and manufactured by BECTON, DICKINSON AND COMPANY (BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.